These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22639485)

  • 1. A random-sum Wilcoxon statistic and its application to analysis of ROC and LROC data.
    Tang LL; Balakrishnan N
    J Stat Plan Inference; 2011 Jan; 141(1):335-344. PubMed ID: 22639485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach.
    Rosner B; Glynn RJ; Lee ML
    Biometrics; 2003 Dec; 59(4):1089-98. PubMed ID: 14969489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable ranking based on the estimated degree of separation for two distributions of data by the length of the receiver operating characteristic curve.
    Maswadeh WM; Snyder AP
    Anal Chim Acta; 2015 May; 876():39-48. PubMed ID: 25998456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An extension of the Wilcoxon Rank-Sum test for complex sample survey data.
    Natarajan S; Lipsitz SR; Fitzmaurice GM; Sinha D; Ibrahim JG; Haas J; Gellad W
    J R Stat Soc Ser C Appl Stat; 2012 Aug; 61(4):653-664. PubMed ID: 23913985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models.
    Rosner B; Glynn RJ
    Biometrics; 2009 Mar; 65(1):188-97. PubMed ID: 18510654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal sample size planning for the Wilcoxon-Mann-Whitney test.
    Happ M; Bathke AC; Brunner E
    Stat Med; 2019 Feb; 38(3):363-375. PubMed ID: 30298671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.
    Matsouaka RA; Singhal AB; Betensky RA
    Stat Methods Med Res; 2018 Aug; 27(8):2384-2400. PubMed ID: 27920364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.
    Matsouaka RA; Betensky RA
    Stat Med; 2015 Feb; 34(3):406-31. PubMed ID: 25393385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROC and LROC analyses of the effects of lesion contrast, size, and signal-to-noise ratio on detectability in PET images.
    Farquhar TH; Llacer J; Sayre J; Tai YC; Hoffman EJ
    J Nucl Med; 2000 Apr; 41(4):745-54. PubMed ID: 10768578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend.
    Lachin JM
    Stat Med; 2011 Nov; 30(25):3057-66. PubMed ID: 22006667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of confidence/credible interval methods for the area under the ROC curve for continuous diagnostic tests with small sample size.
    Feng D; Cortese G; Baumgartner R
    Stat Methods Med Res; 2017 Dec; 26(6):2603-2621. PubMed ID: 26323286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On random-effects meta-analysis.
    Zeng D; Lin DY
    Biometrika; 2015 Jun; 102(2):281-294. PubMed ID: 26688589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending the Mann-Whitney-Wilcoxon rank sum test to survey data for comparing mean ranks.
    Lin T; Chen T; Liu J; Tu XM
    Stat Med; 2021 Mar; 40(7):1705-1717. PubMed ID: 33398899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The appropriateness of the Wilcoxon test in ordinal data.
    Hilton JF
    Stat Med; 1996 Mar; 15(6):631-45. PubMed ID: 8731005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of permutation (randomization) tests in clinical and experimental pharmacology and physiology.
    Ludbrook J
    Clin Exp Pharmacol Physiol; 1994 Sep; 21(9):673-86. PubMed ID: 7820947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Weighted Rank-Sum Procedure for Comparing Samples with Multiple Endpoints.
    Li Q; Liu A; Yu K; Yu KF
    Stat Interface; 2009 Jan; 2(2):197-201. PubMed ID: 19823699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power and sample size calculations for exact conditional tests with ordered categorical data.
    Hilton JF; Mehta CR
    Biometrics; 1993 Jun; 49(2):609-16. PubMed ID: 8369392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Wilcoxon-Mann-Whitney Test and Power against Strong Null.
    Fong Y; Huang Y
    Am Stat; 2019; 73(1):43-49. PubMed ID: 30899120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parametric comparison of diagnostic accuracy with three ordinal diagnostic groups.
    Xiong C; van Belle G; Miller JP; Yan Y; Gao F; Yu K; Morris JC
    Biom J; 2007 Aug; 49(5):682-93. PubMed ID: 17763377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.